Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

SRV sells a housing portfolio to eQ – The sale includes two residential buildings in Tampere and Espoo

SRV GROUP PLC     INVESTOR NEWS    16 MAY 2023  12:05 EEST SRV sells a housing portfolio to eQ – The sale includes two residential buildings in Tampere and Espoo SRV sells a housing portfolio consisting of two residential buildings to a housing fund managed by eQ. The agreements include the residential building Asunto Oy Tampereen Kissanpäivät located in Kissanmaa, Tampere, and Asunto Oy Espoon Anna Sahlsténinkatu 15, located in Perkkaa, Espoo. The total agreement value is EUR 35 million and the projects will be added to SRV’s order backlog for May. Construction in both projects

Gradientech announces appointment of Hilja Ibert and Nedal Safwat to Board of directors

The diagnostics company Gradientech today announces the appointment of Dr Hilja Ibert and Dr Nedal Safwat to the Gradientech Board of Directors, effective May 9, 2023. Following the new appointments, the Board will comprise six directors.Dr Hilja Ibert brings more than 30 years of experience from the clinical diagnostics industry at international companies like Hologic, Becton Dickinson and bioMérieux, including Vice President and General Manager positions within the business areas of Diagnostic systems and Bioscience. Dr Hilja Ibert is currently CEO of Gentian Diagnostics, a Norwegian

CHOSA Oncology AB out-license clinical-stage cancer vaccine candidate to Magle Group

CHOSA Oncology AB, today announces that the company has out-licensed the clinical-stage therapeutic cancer vaccine candidate onilcamotide to Magle Group. Magle Group plans to further develop onilcamotide by use of its proprietary degradable starch microspheres (DSM) technology. The company sees a future potential to combine onilcamotide treatment with its already approved vascular embolic product EmboCept® S.Onilcamotide is a clinical-stage therapeutic cancer vaccine candidate targeting RhoC, an over-expressed protein in metastatic cancer cells. Onilcamotide is a peptide that forms a

Diös strengthens its Group management

Diös’ Transactions Manager Annie Franzon and Head of Investor Relations Johan Dernmar expand their roles and join the company’s Group management. Both Annie and Johan are key employees who clearly reflect Diös’ business focus and drive shareholder value. The change will come into force immediately. Diös is a commercial property company with properties in ten growth cities in northern Sweden, and its business model is built on lettings and property management, projects and business development and transactions. The company is active in a market where enormous investments in Swedish

Report from the Annual General Meeting of Speqta AB (publ) on 16 May 2023

At the annual general meeting (the “AGM”) of Speqta AB (publ), reg. no 556710-8757, (the “Company”), on 16 May 2023 the AGM adopted, inter alia, the following resolutions. For more detailed information regarding the content of the resolutions, please refer to the notice to the AGM and the complete proposals for resolution, which have previously been published and are available on the Company’s website, www.speqta.com. Adoption of the balance sheet and income statement, disposition regarding the Company’s results and discharge from liability The AGM adopted the Company’s

Bravida Finland grows in automation

Bravida Finland acquires Hämeen Kiinteistöautomaatio Oy, thereby expanding its automation activities in southern Finland. The company has sales of around EUR 2.6 million and employs 17 people.Hämeen Kiinteistöautomaatio Oy is active in installation and maintenance services in the fields of automation and energy management. The company is based in Lahti, near Helsinki. “Our strategic objective is to increase our expertise in automation across the entire Group. So we are pleased that new experts in the area are joining Bravida. With this acquisition, we will be able to offer our customers

Valtech named 2023 Global Solution Partner of the Year by Contentful

Valtech announce that it has been named the 2023 Global Solution Partner of the Year by Contentful, a leading composable content platform for digital-first businesses. This award was given as part of Contentful’s inaugural Partner of the Year Awards program.With more than 20 successful projects delivered, Valtech has helped companies across the globe leverage the ContentfulÒ Composable Content Platform to provide the unique digital experiences that are required to succeed in today’s complex marketplace. The partnership between Valtech, with its in-depth knowledge of today's end-to-end

SAGA-RECOMMENDATIONS BY THE NOMINATION COMMITTEE OF TO THE ANNUAL GENERAL MEETING TO BE HELD ON 25 May 2023

Reference is made to the stock exchange notice from Saga Pure ASA dated 4 May 2023, where the Company called for the Annual General Meeting for Saga Pure ASA to be held on 25 May 2023. Enclosed is the Recommendation from the Nomination Committee of Saga Pure ASA for the annual general meeting. For additional information, please contact: Espen Lundaas, CEO, +47 92 43 14 17 About Saga Pure ASA| www.sagapure.com Saga Pure ASA is an investment company with a broad investment mandate.

Q1 Interim Report 1 January – 31 March 2023

Risk Intelligence A/S (“Risk Intelligence” or "Company") hereby publishes the Q1 Interim Report for the period January - March 2023. The report is available on the Company's investor website (investor.riskintelligence.eu).Highlights: · Total reported revenue up by 17% in Q1 2023  · Total invoiced revenue up by 43% in Q1 2023  · Total recurring revenue up by 14% in Q1 2023   · Net Retention Rate 105%   · Costs increased by 19% in Q1 due to higher activity and expansion of sales & marketing   · EBITDA in Q1 -27%   · Net profit in Q1 decreased by 23%  · 4 new clients

New partnership for flame resistant wood and Durable Fire Protection

Thermory and Woodsafe Timber Protection, the largest players in their respective industries, announce collaboration to provide thermally modified and durable fire-protected wood.Woodsafe Timber Protection AB WOODSAFE® Europe's largest manufacturer of durable fire-resistant impregnated wood, and Thermory AS, the world's largest manufacturer of thermally modified wood, announce collaboration for the supply of durable thermally modified fire-resistant wood. Thermory’s real wood products with fire protection are available immediately. “I am very proud of the trust from a well-respected

Voi offers people in Southampton e-scooter safety lessons

Voi scooter in Southampton. Credit: Voi Southampton 16 May 2023: Shared e-scooter company Voi has unveiled dates for safety events aimed at helping riders in Southampton to ride e-scooters safely. The company has arranged a number of online safety webinars from Tuesday 16 May and an in-person event on Saturday 20 May. The in-person e-scooter safety event is free of charge and will take place on Saturday 20 May at 9.30am at Southampton Football Club’s St Mary’s stadium. People taking part in the in-person session can learn more about Voi e-scooters, ask questions and

Voi offers people in Northampton e-scooter safety lessons

Voi scooters at Northampton University. Credit: Voi. Northampton 16 May 2023: Shared e-scooter company Voi has unveiled dates for safety events aimed at helping riders in Northampton to ride e-scooters safely. The company has arranged a number of online safety webinars - with in-person events from Saturday 20 May onwards. The in-person safety events are free of charge and will take place at 9.30am on Saturday 20 May and Saturday 1 July at  Car park 2, University of Northampton Waterside campus. People taking part in the in-person sessions can learn more about Voi e-

BioStock: Tumorad clinical start around the corner for Spago Nanomedical

Encouraged by positive preclinical data with Tumorad, Spago Nanomedical has intensified preparations for the upcoming phase I/IIa study in cancer patients. The company also reported advancements with the contrast agent SpagoPix. BioStock reached out to CEO Mats Hansen for a comment on the Q1 report.Read the interview with Spago Nanomedical's CEO Mats Hansen at biostock.se: https://www.biostock.se/en/2023/05/tumorad-clinical-start-around-the-corner-for-spago-nanomedical/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

Beactica Therapeutics to present breakthrough in YAP–TEAD programme at the Hippo Pathway Drug Development Summit 2023

Beactica Therapeutics AB, the Swedish precision oncology company, today announced that its YAP–TEAD programme has been selected for an oral presentation at the 2[nd] Hippo Pathway Targeted Drug Development Summit 2023. The conference will take place on May 23–35, 2023, in Boston, Massachusetts.Dr Peter Brandt, Head of Chemistry, will present a talk entitled Specific Degraders of TEADs Based on Interface 3 Binding on Thursday May 25, 2023, at 2:00 – 2:30 PM in the Boston Park Plaza. The presentation will showcase a breakthrough in the development of novel cell-active targeted degraders of

Invitation to Ericsson quarterly sustainability and responsible business update

Ericsson (NASDAQ: ERIC) invites investors and financial analysts to a briefing session focused on sustainability and responsible business at Ericsson. The session will include presentations by Heather Johnsson, Head of Sustainability and Corporate Responsibility, and Jan Sprafke, acting Chief Compliance Officer. The session will also include a Q&A where participants can ask questions. Date: May 30, 2023 Time: 3-4 pm CEST Webcast: please use this link  to join the webcast. If you want to ask a question, please access dial-in information

(Em)powering the future – GF Piping Systems enters the battery manufacturing market

Swiss flow solutions provider GF Piping Systems is applying its knowledge of lightweight and corrosion-free systems to the needs of the battery sector, focusing on applications from energy-efficient cooling and water treatment to process automation. The company will attend the Battery Show event, from 23 to 25 May 2023 in Stuttgart, Germany.The battery industry plays an essential role in facilitating the transition towards a decarbonized future – in Europe alone, new production capacities of around 1.4 TWh of battery cell capacity per year are expected by 2030. However, it is crucial to

Katalysen Ventures AB announces venture development agreement for IPO project in Manico AB

Katalysen Ventures AB (publ) ("Katalysen") and Manico AB ("Manico") have announced a venture development agreement to prepare for Manico's upcoming IPO, in addition to Katalysen exercising options and acquiring new shares worth SEK 925 950 in Manico.Manico is a leading provider of cutting-edge software and hardware for educational purposes, with a proprietary software on touch screens that enables collaboration between multiple users at the same time. Manico serves a diverse range of clients, including schools, elderly homes, museums, hospitals, hotels, shopping malls, restaurants, and more.

BioStock: BrainCool’s CEO on the purchase agreement in the US

BrainCool has signed a purchase agreement for IQool System with Vanderbilt Health in the US. The aim is to make the medical device available in the 74 hospitals that are part of that health system. BioStock talked to BrainCool’s CEO Martin Waleij about the agreement and its potential commercial benefits.Read the full interview with Martin Waleij at biostock.se: https://www.biostock.se/en/2023/05/braincools-ceo-on-the-purchase-agreement-in-the-us/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Pia Marions, former Carnegie CFO, is to be appointed to the board of directors of Carnegie Group

Pia Marions and Gustav Axelson is to be appointed as new directors of Carnegie Holding AB (Carnegie Group) and Carnegie Investment Bank AB.Ms Marions has many years of experience in the financial industry, most recently as CFO of Skandia. She served as the CFO of Carnegie from 2010 to 2015. “I am delighted that Pia is returning to Carnegie as a director. She thoroughly understands the company, its culture and the driving forces that make Carnegie one of the foremost advisers and asset managers in the Nordics,” says Carnegie Group Board Chair Anders Johnsson. “With her in-depth and

Salmon Evolution ASA: Invitation to presentation of first quarter 2023 results

Salmon Evolution will present its first quarter 2023 results, followed by a Q&A session, on Tuesday, 23 May 2023, at Hotel Continental in Oslo at 08:00 CET. A taste of our delicious locally smoked salmon from Indre Harøy will be served from 07:45 CET. Participants may also follow the presentation and submit questions through a live webcast available on www.salmonevolution.no, or with the following link: https://events.webcast.no/viewer-registration/OGhLeEcM/register 

SimCorp A/S - Major shareholder announcement

May 16, 2023 Company announcement no 9/2023Pursuant to Section 30 of the Capital Markets Act, please be informed that SimCorp A/S on May 15, 2023, was informed by BLS Capital Fondsmæglerselskab A/S that BLS Capital Fondsmæglerselskab A/S now holds 8.95% of the voting rights in SimCorp A/S. The shares are traded at NASDAQ Copenhagen A/S. Questions may be addressed to Anders Hjort, VP, Head of Investor Relations, SimCorp A/S (+45 3544 8800).

NRC Group ASA - Appointed to a maintenance contract in Finland - EUR 14,3 million

Finnish Transport Infrastructure Agency (FTIA) has appointed NRC Group Finland, a company wholly owned by NRC Group ASA, to a contract for track and signalling maintenance on maintenance area 9, which ranges from Oulu to Kokkola and Iisalmi. The contract is valued at approximately EUR 14,3 million. The work will commence in November 2023, and is scheduled for completion in October 2026, with an additional 2+2 option period. Closing date for submission of complaints is 14 days from today, and formal contractual signing can take place after this period at the earliest. For further

DanCann Pharma A/S: The exercise period for warrants of series TO 2 begins today

COPENHAGEN, Denmark, 16 May 2023 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, hereby announces that Today is the first day of the exercise period for DanCann Pharma’s warrants of series TO 2 which were issued in connection with the Company’s rights issue of units that was announced on 21 October 2022.  Holders of warrants of series TO 2 have, for each warrant, the right to subscribe for one (1) new share in DanCann Pharma at a price of DKK 0.36 per share. The exercise period runs until and including 31 May 2023.Information

There are no items matching the current filter
There are no more items matching the current filter
Back to top